New perspectives on innovative drug discovery: an overview.

Despite advances in technology, drug discovery is still a lengthy, expensive, difficult, and inefficient process, with a low rate of success. Today, advances in biomedical science have brought about great strides in therapeutic interventions for a wide spectrum of diseases. The advent of biochemical techniques and cutting-edge bio/chemical technologies has made available a plethora of practical approaches to drug screening and design. In 2010, the total sales of the global pharmaceutical market will reach 600 billion US dollars and expand to over 975 billion dollars by 2013. The aim of this review is to summarize available information on contemporary approaches and strategies in the discovery of novel therapeutic agents, especially from the complementary and alternative medicines, including natural products and traditional remedies such as Chinese herbal medicine.

[1]  D. Newman,et al.  Microbial antitumor drugs: natural products of microbial origin as anticancer agents. , 2009, Current opinion in investigational drugs.

[2]  Thomas H Segall-Shapiro,et al.  Creation of a Bacterial Cell Controlled by a Chemically Synthesized Genome , 2010, Science.

[3]  J. Rosenstock,et al.  Titration of inhaled human insulin (Exubera) in a treat-to-target regimen for patients with type 2 diabetes. , 2010, Diabetes technology & therapeutics.

[4]  T. Illmer,et al.  The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic review. , 2009, Cancer treatment reviews.

[5]  The transatlantic rift in genetically modified food policy , 2007 .

[6]  F. Shanahan,et al.  The gut flora as a forgotten organ , 2006, EMBO reports.

[7]  T. Robak.  Treatment of chronic lymphoid leukemias with monoclonal antibodies: current place and perspectives , 2008 .

[8]  M. Tremblay,et al.  Statins could be used to control replication of some viruses, including HIV-1. , 2005, Viral immunology.

[9]  Xaviera Thomas,et al.  Arsenic: a beneficial therapeutic poison - a historical overview. , 2009, Adler Museum bulletin.

[10]  K. Sweder,et al.  The role of genetic toxicology in drug discovery and optimization. , 2008, Current drug metabolism.

[11]  D. Bentley.  The Human Genome Project--an overview. , 2000, Medicinal research reviews.

[12]  Min Yang,et al.  CDA-II, a urinary preparation, induces growth arrest and apoptosis of human leukemia cells through inactivation of nuclear factor-kappaB in a caspase-dependent manner. , 2009, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.

[13]  G. Bar-Sela,et al.  Curcumin as an anti-cancer agent: review of the gap between basic and clinical applications. , 2010, Current medicinal chemistry.

[14]  N. Seidah,et al.  Chloroquine is a potent inhibitor of SARS coronavirus infection and spread , 2005, Virology Journal.

[15]  J. Hao,et al.  Inhibitory effect of bionic fungicide 2-allylphenol on Botrytis cinerea (Pers. ex Fr.) in vitro. , 2009, Pest management science.

[16]  Y. Li,et al.  Synthesis and biological activity of Wuweizisu C and analogs. , 2009, Current topics in medicinal chemistry.

[17]  J. Conlon.  Reflections on a systematic nomenclature for antimicrobial peptides from the skins of frogs of the family Ranidae , 2008, Peptides.

[18]  Burkhard Haefner,et al.  Drugs from the deep: marine natural products as drug candidates. , 2003, Drug discovery today.

[19]  J. Vernon.  Examining the link between price regulation and pharmaceutical R&D investment. , 2005, Health economics.

[20]  G. Edwards‐Jones,et al.  Plant metabolites and nutritional quality of vegetables. , 2008, Journal of food science.

[21]  Charles C. Persinger,et al.  How to improve R&D productivity: the pharmaceutical industry's grand challenge , 2010, Nature Reviews Drug Discovery.

[22]  G. Rishton,et al.  Failure and success in modern drug discovery: guiding principles in the establishment of high probability of success drug discovery organizations. , 2005, Medicinal chemistry (Shariqah (United Arab Emirates)).

[23]  Marc Van Ranst,et al.  In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine , 2004, Biochemical and Biophysical Research Communications.

[24]  Clara Verges,et al.  The year's new drugs & biologics - 2008. , 2009, Drug news & perspectives.

[25]  W. Jelkmann,et al.  Erythropoiesis stimulating agents and techniques: a challenge for doping analysts. , 2009, Current medicinal chemistry.

[26]  F. Russo,et al.  Lactobacillus rhamnosus GG influences polyamine metabolism in HGC-27 gastric cancer cell line: a strategy toward nutritional approach to chemoprevention of gastric cance. , 2010, Current pharmaceutical design.

[27]  Yoo-Hwa Park,et al.  Multifaceted therapeutic benefits of Ginkgo biloba L.: chemistry, efficacy, safety, and uses. , 2007, Journal of food science.

[28]  S. Pan,et al.  Ethanol Extract of Fructus Schisandrae Decreases Hepatic Triglyceride Level in Mice Fed with a High Fat/Cholesterol Diet, with Attention to Acute Toxicity , 2011, Evidence-based complementary and alternative medicine : eCAM.

[29]  J. Kuhlmann.  The applications of biomarkers in early clinical drug development to improve decision-making processes. , 2007, Ernst Schering Research Foundation workshop.

[30]  S. Pan,et al.  Bicyclol, a synthetic dibenzocyclooctadiene derivative, decreases hepatic lipids but increases serum triglyceride level in normal and hypercholesterolaemic mice , 2007, The Journal of pharmacy and pharmacology.

[31]  Ara Darzi,et al.  The human gut microbiome: Implications for future health care , 2008, Current gastroenterology reports.

[32]  T. Lai,et al.  Effect of CDA-II, urinary preparation, on lipofuscin, lipid peroxidation and antioxidant systems in young and middle-aged rat brain. , 2001, The American journal of Chinese medicine.

[33]  Erik Mosekilde,et al.  Integrating systems approaches into pharmaceutical sciences. , 2008, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[34]  Janice M. Reichert,et al.  A guide to drug discovery: Trends in development and approval times for new therapeutics in the United States , 2003, Nature Reviews Drug Discovery.

[35]  M. López-Lázaro.  Distribution and biological activities of the flavonoid luteolin. , 2009, Mini reviews in medicinal chemistry.

[36]  R. Pallela,et al.  Anti-photoaging and Photoprotective Compounds Derived from Marine Organisms , 2010, Marine drugs.

[37]  K. S. Lam,et al.  Discovery and development of the anticancer agent salinosporamide A (NPI-0052). , 2009, Bioorganic & medicinal chemistry.

[38]  [From teprotide to captopril. Rational design of ACE inhibitors]. , 2003, Pharmazie in unserer Zeit.

[39]  Weiliang Zhu,et al.  [Advances in the study of berberine and its derivatives]. , 2008, Yao xue xue bao = Acta pharmaceutica Sinica.

[40]  A. Budd,et al.  The DExD/H-box helicase Dicer-2 mediates the induction of antiviral activity in drosophila , 2008, Nature Immunology.

[41]  S. Chhibber,et al.  Therapeutic potential of bacteriophage in treating Klebsiella pneumoniae B5055-mediated lobar pneumonia in mice. , 2008, Journal of medical microbiology.

[42]  Janice M Reichert,et al.  Monoclonal antibodies as innovative therapeutics. , 2008, Current pharmaceutical biotechnology.

[43]  Soy Isoflavones.  Soy isoflavones. , 2020, Alternative medicine review : a journal of clinical therapeutic.

[44]  X. Su,et al.  Discovery, mechanisms of action and combination therapy of artemisinin , 2009, Expert review of anti-infective therapy.

[45]  G. Rishton,et al.  Natural products as a robust source of new drugs and drug leads: past successes and present day issues. , 2008, The American journal of cardiology.

[46]  Yahui Wei,et al.  [Research advances of Huperzia serrata (Thunb.) Trev]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[47]  Song Xue,et al.  Biopotentials of marine sponges from China oceans: past and future. , 2003, Biomolecular engineering.

[48]  G. Şener,et al.  Resveratrol protects against methotrexate-induced hepatic injury in rats. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[49]  A. Rescigno.  The two faces of pharmacokinetics. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[50]  Hong Zhou,et al.  Generation of stable cell lines by site-specific integration of transgenes into engineered Chinese hamster ovary strains using an FLP-FRT system. , 2010, Journal of biotechnology.

[51]  E. Romanowski,et al.  A Review of Antimicrobial Peptides and Their Therapeutic Potential as Anti-Infective Drugs , 2005, Current eye research.

[52]  R. Yu,et al.  Clinical and cosmeceutical uses of hydroxyacids. , 2009, Clinics in dermatology.

[53]  R. Blaese.  Development of Gene Therapy for Immunodeficiency: Adenosine Deaminase Deficiency , 1993, Pediatric Research.

[54]  K. Erdmann,et al.  The possible roles of food-derived bioactive peptides in reducing the risk of cardiovascular disease. , 2008, The Journal of nutritional biochemistry.

[55]  C. Tautermann,et al.  G-protein-coupled receptor-focused drug discovery using a target class platform approach. , 2009, Drug discovery today.

[56]  D. Barra,et al.  Amphibian skin: a promising resource for antimicrobial peptides. , 1995, Trends in biotechnology.

[57]  H. Grabowski,et al.  Are the economics of pharmaceutical research and development changing? , 2012, PharmacoEconomics.

[58]  Michael J Zaworotko,et al.  Expanding the scope of crystal form evaluation in pharmaceutical science. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[59]  Marcy J. Balunas,et al.  Drug discovery from natural sources , 2006, The AAPS Journal.

[60]  Ruth E Ley,et al.  Obesity and the human microbiome , 2010, Current opinion in gastroenterology.

[61]  Ana Martínez.  Marine-derived drugs in neurology. , 2007, Current opinion in investigational drugs.

[62]  S. Burzynski.  Antineoplastons: history of the research (I). , 1986, Drugs under experimental and clinical research.

[63]  Ling-Hao Li,et al.  [Progression of foundational and clinical studies on use of arsenic trioxide in treatment of lymphoma--review]. , 2007, Zhongguo shi yan xue ye xue za zhi.

[64]  O. Chun,et al.  Soy isoflavones as safe functional ingredients. , 2007, Journal of medicinal food.

[65]  Scott A. Brown,et al.  HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail. , 2008, Frontiers in bioscience : a journal and virtual library.

[66]  Janice M Reichert,et al.  Finding value in the U.S. Food and Drug Administration's Fast Track program. , 2009, Drug news & perspectives.

[67]  C. M. Pérez.  Can ginkgo biloba combat diseases? , 2009, Puerto Rico health sciences journal.

[68]  Peter Watson,et al.  Live cell imaging for target and drug discovery. , 2009, Drug news & perspectives.

[69]  D J Barlow,et al.  Phytochemical informatics and virtual screening of herbs used in Chinese medicine. , 2010, Current pharmaceutical design.

[70]  W. Verstraete,et al.  The intestinal environment in health and disease - recent insights on the potential of intestinal bacteria to influence human health. , 2009, Current pharmaceutical design.

[71]  Se-kwon Kim,et al.  Angiotensin-I-Converting Enzyme (ACE) Inhibitors from Marine Resources: Prospects in the Pharmaceutical Industry , 2010, Marine drugs.

[72]  Rui Wang,et al.  Molecular dynamics simulations of interaction between protein-tyrosine phosphatase 1B and a bidentate inhibitor , 2006, Acta Pharmacologica Sinica.

[73]  S. Ichinose,et al.  Statin-induced inhibition of HIV-1 release from latently infected U1 cells reveals a critical role for protein prenylation in HIV-1 replication. , 2008, Microbes and infection.

[74]  R. Aluko.  Technology for the production and utilization of food protein-derived anti-hypertensive peptides: a review. , 2007, Recent patents on biotechnology.

[75]  Linxiang Zhao,et al.  Ethacrynic acid butyl-ester induces apoptosis in leukemia cells through a hydrogen peroxide mediated pathway independent of glutathione S-transferase P1-1 inhibition. , 2007, Cancer research.

[76]  T. Ganapathi,et al.  Expression of Hepatitis B Surface Antigen in Transgenic Banana Plants and NTI Cell Line of Tobacco , 2003 .

[77]  P. Georgel,et al.  Genetic and epigenetic regulations of prostate cancer by genistein. , 2009, Drug news & perspectives.

[78]  J. Wittes,et al.  A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum. , 2005, The American journal of tropical medicine and hygiene.

[79]  F. Carroll.  Epibatidine structure-activity relationships. , 2004, Bioorganic & medicinal chemistry letters.

[80]  Shuji Ogino,et al.  Aspirin and the risk of colorectal cancer in relation to the expression of COX-2. , 2007, The New England journal of medicine.

[81]  N. Grubhofer.  Vaccine Adjuvants Revisited , 2008 .

[82]  Jian-Guo Jiang,et al.  Chinese medicine and its modernization demands. , 2008, Archives of medical research.

[83]  U. Lindequist,et al.  Evaluation of the in vitro anticancer, antimicrobial and antioxidant activities of some Yemeni plants used in folk medicine. , 2009, Die Pharmazie.

[84]  S. Bembenek,et al.  Ligand binding efficiency: trends, physical basis, and implications. , 2008, Journal of medicinal chemistry.

[85]  T. Tabira.  Immunization therapy for Alzheimer disease: a comprehensive review of active immunization strategies. , 2010, The Tohoku journal of experimental medicine.

[86]  L. Mohassel,et al.  Arsenic trioxide as first-line treatment for acute promyelocytic leukemia. , 2009, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[87]  M. Luo,et al.  Medicinal chemistry of paclitaxel and its analogues. , 2009, Current medicinal chemistry.

[88]  A. Trovato-Salinaro,et al.  The hormetic role of dietary antioxidants in free radical-related diseases. , 2010, Current pharmaceutical design.

[89]  R. Millán-Guerrero,et al.  Subcutaneous histamine versus botulinum toxin type A in migraine prophylaxis: a randomized, double‐blind study , 2009, European journal of neurology.

[90]  C. Sen,et al.  Tocotrienols: the emerging face of natural vitamin E. , 2007, Vitamins and hormones.

[91]  Liu Gt.  [From the study of Fructus schizandrae to the discovery of biphenyl dimethyl-dicarboxylate]. , 1983 .

[92]  Hannah M. Jones,et al.  Modelling and PBPK Simulation in Drug Discovery , 2009, The AAPS Journal.

[93]  David W Green,et al.  Tissue bionics: examples in biomimetic tissue engineering , 2008, Biomedical materials.

[94]  G. Schwartsmann,et al.  Marine-derived anticancer agents in clinical trials , 2003, Expert opinion on investigational drugs.

[95]  A. Nzila,et al.  Anticancer agents against malaria: time to revisit? , 2010, Trends in parasitology.

[96]  Public and private sector contributions to the discovery and development of "impact" drugs. , 2002, American journal of therapeutics.

[97]  A. Kong,et al.  Molecular Targets of Dietary Phenethyl Isothiocyanate and Sulforaphane for Cancer Chemoprevention , 2010, The AAPS Journal.

[98]  V. Adamo,et al.  Insertional mutagenesis and development of malignancies induced by integrating gene delivery systems: implications for the design of safer gene-based interventions in patients. , 2009, Drug news & perspectives.

[99]  Xiong Mao-min.  Review of arsenic trioxide effect on human hepatocarcinoma , 2006 .

[100]  M. Moța,et al.  Soya--the medicine food product. , 2007, Romanian journal of internal medicine = Revue roumaine de medecine interne.

[101]  Nigel Greene,et al.  Early toxicity screening strategies. , 2009, Current opinion in drug discovery & development.

[102]  D. Faulkner.  Marine natural products. , 2000, Natural product reports.

[103]  D. Robledo,et al.  Antileishmanial properties of tropical marine algae extracts. , 2008, Fitoterapia.

[104]  Geng-tao Liu.  Bicyclol: a novel drug for treating chronic viral hepatitis B and C. , 2009, Medicinal chemistry (Shariqah (United Arab Emirates)).

[105]  Christopher T. Walsh,et al.  Antibiotics for Emerging Pathogens , 2009, Science.

[106]  Mattheos A G Koffas,et al.  Trends in microbial synthesis of natural products and biofuels. , 2009, Advances in enzymology and related areas of molecular biology.

[107]  Philip G. Williams,et al.  Panning for chemical gold: marine bacteria as a source of new therapeutics. , 2009, Trends in biotechnology.

[108]  D. Gurwitz.  Malaria drugs: clues from malaria resistance genetics , 2009 .

[109]  David H Sherman,et al.  Biosynthetic pathway and gene cluster analysis of curacin A, an antitubulin natural product from the tropical marine cyanobacterium Lyngbya majuscula. , 2004, Journal of natural products.

[110]  Wei Hu,et al.  [Synthesis of metabolites of bicyclol]. , 2007, Yao xue xue bao = Acta pharmaceutica Sinica.

[111]  S. Pan,et al.  Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice. , 2006, European journal of pharmacology.

[112]  W. Au,et al.  Arsenic trioxide: safety issues and their management , 2008, Acta Pharmacologica Sinica.

[113]  David J Newman,et al.  Natural products as sources of new drugs over the period 1981-2002. , 2003, Journal of natural products.

[114]  T. Szekeres,et al.  Antitumor effects of KITC, a new resveratrol derivative, in AsPC-1 and BxPC-3 human pancreatic carcinoma cells , 2009, Investigational New Drugs.

[115]  T. Molinski,et al.  Drug development from marine natural products , 2009, Nature Reviews Drug Discovery.

[116]  M. Petroski,et al.  The ubiquitin system, disease, and drug discovery , 2008, BMC Biochemistry.

[117]  W. Noble,et al.  Minocycline as a potential therapeutic agent in neurodegenerative disorders characterized by protein misfolding , 2009, Prion.

[118]  Mukul Sharma,et al.  Clinical status of anti-cancer agents derived from marine sources. , 2008, Anti-cancer agents in medicinal chemistry.

[119]  A. Chesson,et al.  Anti-Inflammatory Implications of the Microbial Transformation of Dietary Phenolic Compounds , 2008, Nutrition and cancer.

[120]  M. Gillick.  Controlling Off-Label Medication Use , 2009, Annals of Internal Medicine.

[121]  A. Tabarrok.  From off-label prescribing towards a new FDA. , 2009, Medical hypotheses.

[122]  R. Abagyan,et al.  Structure-based discovery of natural-product-like TNF-α inhibitors. , 2010, Angewandte Chemie.

[123]  M. Tallman,et al.  Arsenic trioxide: new clinical experience with an old medication in hematologic malignancies. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[124]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[125]  Detrusor overactivity successfully treated with duloxetine , 2007, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[126]  J. Hervé.  Therapeutic potential of peptide motifs--part II. , 2009, Current pharmaceutical design.

[127]  Brian M. Murphy,et al.  Stability of Protein Pharmaceuticals: An Update , 2010, Pharmaceutical Research.

[128]  C. Sen,et al.  Tocotrienols in health and disease: the other half of the natural vitamin E family. , 2007, Molecular aspects of medicine.

[129]  S. Lampel,et al.  The druggable genome: an update. , 2005, Drug discovery today.

[130]  S. Basano,et al.  Antimalarials and the fight against malaria in Brazil , 2009, Therapeutics and clinical risk management.

[131]  D. Chauhan,et al.  A novel proteasome inhibitor NPI-0052 as an anticancer therapy , 2006, British Journal of Cancer.

[132]  J. Stevens,et al.  Strategic applications of toxicogenomics in early drug discovery. , 2008, Current opinion in pharmacology.

[133]  P. Hogg,et al.  Arsenical-based cancer drugs. , 2007, Cancer treatment reviews.

[134]  Mark R. Trusheim,et al.  Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers , 2007, Nature Reviews Drug Discovery.

[135]  Yucheng Gu,et al.  Secondary metabolites from the South China Sea invertebrates: chemistry and biological activity. , 2006, Current medicinal chemistry.

[136]  R. D. Phillips,et al.  Plant food-derived Angiotensin I converting enzyme inhibitory peptides. , 2009, Journal of agricultural and food chemistry.

[137]  J. Conlon,et al.  Antimicrobial peptides from ranid frogs: taxonomic and phylogenetic markers and a potential source of new therapeutic agents. , 2004, Biochimica et biophysica acta.

[138]  S. Akira,et al.  RIG-I-like antiviral protein in flies , 2008, Nature Immunology.

[139]  E. Borden,et al.  Personalizing medicine for cancer: the next decade , 2010, Nature Reviews Drug Discovery.

[140]  H. Dürk.  Maintenance Therapy for Multiple Myeloma with Particular Emphasis on Thalidomide , 2006, Oncology Research and Treatment.

[141]  Mohamed O. Othman,et al.  Alterations in intestinal microbial flora and human disease , 2008, Current opinion in gastroenterology.

[142]  Sumio Sugano,et al.  Human Gene and Protein Database (HGPD): a novel database presenting a large quantity of experiment-based results in human proteomics , 2009, Nucleic Acids Res..

[143]  Li Li Tang,et al.  Potential therapeutic targets of huperzine A for Alzheimer's disease and vascular dementia. , 2008, Chemico-biological interactions.

[144]  C. Drewke,et al.  Ginkgo biloba and ginkgotoxin. , 2010, Journal of natural products.

[145]  Luisa Bracci,et al.  Branched peptides as therapeutics. , 2008, Current protein & peptide science.

[146]  K. Pathak,et al.  Pharmaceutical product development technologies based on the biopharmaceutical classification system. , 2009, Die Pharmazie.

[147]  S. Soignet,et al.  Risk/benefit profile of arsenic trioxide. , 2001, The oncologist.

[148]  J. Berenson,et al.  Arsenic compounds in the treatment of multiple myeloma: a new role for a historical remedy. , 2006, Clinical lymphoma & myeloma.

[149]  S. Pan,et al.  Schisandrin B from Schisandra chinensis reduces hepatic lipid contents in hypercholesterolaemic mice , 2008, The Journal of pharmacy and pharmacology.

[150]  R. Eglen,et al.  Photoproteins: important new tools in drug discovery. , 2008, Assay and drug development technologies.

[151]  J. Hervé.  Therapeutic potential of peptide motifs - part III. , 2010, Current pharmaceutical design.

[152]  T. Kawada,et al.  Bixin regulates mRNA expression involved in adipogenesis and enhances insulin sensitivity in 3T3-L1 adipocytes through PPARgamma activation. , 2009, Biochemical and biophysical research communications.

[153]  Matthew Clark,et al.  Developing technologies in biodefense research: computational drug design , 2009 .

[154]  Edwin L. Cooper,et al.  Drug Discovery: Is it Relevant to Complementary and Alternative Medicine (CAM)? , 2004 .

[155]  J. Meyerhardt,et al.  Aspirin dose and duration of use and risk of colorectal cancer in men. , 2008, Gastroenterology.

[156]  P. Bye,et al.  Recombinant activated factor VII for massive hemoptysis in patients with cystic fibrosis. , 2009, Chest.

[157]  李贺,et al.  Review of arsenic trioxide effect on human hepatocarcinoma , 2006 .

[158]  Woan‐Ruoh Lee,et al.  The wrinkles soothing effect on the middle and lower face by intradermal injection of botulinum toxin type A , 2008, International journal of dermatology.

[159]  L. Gerwick,et al.  Marine natural product drug discovery: Leads for treatment of inflammation, cancer, infections, and neurological disorders , 2010, Immunopharmacology and immunotoxicology.

[160]  D. Faulkner,et al.  Marine natural products. , 2000, Natural product reports.

[161]  Yoshimasa Nakamura,et al.  Electrophiles in Foods: The Current Status of Isothiocyanates and Their Chemical Biology , 2010, Bioscience, biotechnology, and biochemistry.

[162]  B. Cukrowska,et al.  Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases. , 2004, Immunology letters.

[163]  B. Neilan,et al.  Development of Taxol and other endophyte produced anti-cancer agents. , 2008, Recent patents on anti-cancer drug discovery.

[164]  R. Herzog,et al.  Gene therapy approaches to induce tolerance in autoimmunity by reshaping the immune system. , 2009, Current opinion in investigational drugs.

[165]  Kotaro Aihara,et al.  Casein-derived tripeptide, Val-Pro-Pro (VPP), modulates monocyte adhesion to vascular endothelium. , 2009, Journal of atherosclerosis and thrombosis.

[166]  Joana M. Xavier,et al.  The role of p53 in apoptosis. , 2010, Discovery medicine.

[167]  Shu-Hua Tai,et al.  A systematic review and meta‐analysis on the therapeutic equivalence of statins , 2010, Journal of clinical pharmacy and therapeutics.

[168]  A. Graul.  Promoting, improving and accelerating the drug development and approval processes. , 2009, Drug news & perspectives.

[169]  Sushama Talegaonkar,et al.  Emerging significance of flavonoids as P-glycoprotein inhibitors in cancer chemotherapy. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[170]  F. Baba,et al.  Lycopene, an antioxidant carotenoid, attenuates testicular injury caused by ischemia/reperfusion in rats. , 2009, The Tohoku journal of experimental medicine.

[171]  R. Williams.  Review article: bacterial flora and pathogenesis in hepatic encephalopathy , 2007, Alimentary pharmacology & therapeutics.

[172]  H. Hanai,et al.  Curcumin has bright prospects for the treatment of inflammatory bowel disease. , 2009, Current pharmaceutical design.

[173]  R. Schilsky.  Personalized medicine in oncology: the future is now , 2010, Nature Reviews Drug Discovery.

[174]  Alicia R. Desilets,et al.  Role of Huperzine a in the Treatment of Alzheimer's Disease , 2009, The Annals of pharmacotherapy.

[175]  M. Mancuso,et al.  Neuroprotective effects of tetracyclines: molecular targets, animal models and human disease. , 2009, CNS & neurological disorders drug targets.

[176]  Ara Darzi,et al.  Autobionics: a new paradigm in regenerative medicine and surgery. , 2010, Regenerative medicine.

[177]  Á. Simonyi,et al.  Resveratrol as a Therapeutic Agent for Neurodegenerative Diseases , 2010, Molecular Neurobiology.

[178]  N. Nagelkerke,et al.  Resistance to HIV-1 infection among persistently seronegative prostitutes in Nairobi, Kenya , 1996, The Lancet.

[179]  Angus Nedderman,et al.  In vitro screening techniques for reactive metabolites for minimizing bioactivation potential in drug discovery. , 2008, Current drug metabolism.

[180]  Kazunori Kato,et al.  Cancer-targeting gene therapy using tropism-modified adenovirus. , 2007, Anticancer research.

[181]  T. Shirakawa.  Clinical trial design for adenoviral gene therapy products. , 2009, Drug news & perspectives.

[182]  G. Vinderola,et al.  Proposed Model: Mechanisms of Immunomodulation Induced by Probiotic Bacteria , 2007, Clinical and Vaccine Immunology.

[183]  G. T. Liu.  [From the study of Fructus schizandrae to the discovery of biphenyl dimethyl-dicarboxylate]. , 1983, Yao xue xue bao = Acta pharmaceutica Sinica.

[184]  J. Rauha,et al.  Natural products in the process of finding new drug candidates. , 2004, Current medicinal chemistry.

[185]  W. Debinski.  Molecular targeting with recombinant cytotoxins for the treatment of brain tumors , 2008 .

[186]  Stefan Günther,et al.  SuperPred: drug classification and target prediction , 2008, Nucleic Acids Res..

[187]  S. Pan,et al.  New Perspectives on Chinese Herbal Medicine (Zhong-Yao) Research and Development , 2011, Evidence-based complementary and alternative medicine : eCAM.

[188]  A. Shah,et al.  Effect of camel urine on the cytological and biochemical changes induced by cyclophosphamide in mice. , 1996, Journal of ethnopharmacology.

[189]  B. Munos.  Lessons from 60 years of pharmaceutical innovation , 2009, Nature Reviews Drug Discovery.

[190]  S. Erdine.  Compliance With the Treatment of Hypertension: The Potential of Combination Therapy , 2010, Journal of clinical hypertension.

[191]  William Fenical,et al.  Widespread and Persistent Populations of a Major New Marine Actinomycete Taxon in Ocean Sediments , 2002, Applied and Environmental Microbiology.

[192]  S. Soignet,et al.  Diagnosis and treatment of acute promyelocytic leukemia , 2007, Current oncology reports.

[193]  Jian-ping Liu,et al.  [Efficacy of arsenic trioxide for acute promyelocytic leukemia: a systematic review and meta-analysis]. , 2009, Zhong xi yi jie he xue bao = Journal of Chinese integrative medicine.

[194]  S. Di Bella,et al.  Management of antibiotic resistance in the intensive care unit setting , 2010, Expert review of anti-infective therapy.

[195]  E. Tobinick.  The value of drug repositioning in the current pharmaceutical market. , 2009, Drug news & perspectives.

[196]  S Grabley,et al.  Bioactive agents from natural sources: trends in discovery and application. , 1999, Advances in biochemical engineering/biotechnology.

[197]  I. Goryanin,et al.  Human metabolic network reconstruction and its impact on drug discovery and development. , 2008, Drug discovery today.

[198]  L. Goldfrank,et al.  Medical toxicology. , 1992, JAMA.

[199]  E. Arinç,et al.  Evaluation of the protective effects of quercetin, rutin, naringenin, resveratrol and trolox against idarubicin-induced DNA damage. , 2010, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[200]  Gabriella Molinari,et al.  Natural products in drug discovery: present status and perspectives. , 2009, Advances in Experimental Medicine and Biology.

[201]  T. Adrian.  Novel marine-derived anti-cancer agents. , 2007, Current pharmaceutical design.

[202]  Humayoun Akhtar,et al.  Food and therapeutic product interactions - a therapeutic perspective. , 2009, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[203]  M. Liong,et al.  Effects of a Lactobacillus casei synbiotic on serum lipoprotein, intestinal microflora, and organic acids in rats. , 2006, Journal of dairy science.

[204]  Custer Ll,et al.  The role of genetic toxicology in drug discovery and optimization. , 2008 .

[205]  John S Janiszewski,et al.  Perspectives on bioanalytical mass spectrometry and automation in drug discovery. , 2008, Current drug metabolism.

[206]  J Drews,et al.  The role of innovation in drug development. , 1997, Nature biotechnology.

[207]  W. Fenical.  New pharmaceuticals from marine organisms. , 1997, Trends in biotechnology.

[208]  K. Piwocka,et al.  The promise of slow down ageing may come from curcumin. , 2010, Current pharmaceutical design.

[209]  R. Quirion,et al.  Polyphenols as potential inhibitors of amyloid aggregation and toxicity: possible significance to Alzheimer's disease. , 2008, Mini reviews in medicinal chemistry.

[210]  Jonathan W. Essex,et al.  Prediction of protein–ligand binding affinity by free energy simulations: assumptions, pitfalls and expectations , 2010, J. Comput. Aided Mol. Des..

[211]  Roksana Parvin,et al.  Protective effect of tomato against adrenaline-induced myocardial infarction in rats. , 2009, Bangladesh Medical Research Council bulletin.

[212]  A. Lugasi,et al.  [A comparison of chemical composition and nutritional value of organically and conventionally grown plant derived foods]. , 2006, Orvosi hetilap.

[213]  Aibin Shi,et al.  Antitumor effect of substituted quinolines in breast cancer cells , 2008 .

[214]  N. Kovačević,et al.  Arbutin content and antioxidant activity of some Ericaceae species. , 2009, Die Pharmazie.

[215]  A. Casini,et al.  New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications , 2008, FEBS letters.

[216]  Min Yang,et al.  Human urine extract CDA-2 induces apoptosis of myelodysplastic syndrome-derived MUTZ-1 cells through the PI3K/Akt signaling pathway in a caspase-3-dependent manner , 2008, Acta Pharmacologica Sinica.

[217]  Jie Liu,et al.  Mineral Arsenicals in Traditional Medicines: Orpiment, Realgar, and Arsenolite , 2008, Journal of Pharmacology and Experimental Therapeutics.

[218]  Xiaoyuan Chen,et al.  Has Molecular and Cellular Imaging Enhanced Drug Discovery and Drug Development? , 2008, Drugs in R&D.

[219]  Jiri Aubrecht,et al.  Voluntary exploratory data submissions to the US FDA and the EMA: experience and impact , 2010, Nature Reviews Drug Discovery.

[220]  C. Ponticelli,et al.  Once-a-day administration of everolimus, cyclosporine, and steroid after renal transplantation: a review of the rationale. , 2010, Transplantation proceedings.